postintervention

Related by string. * * *

Related by context. All words. (Click for frequent words.) 81 preintervention 75 posttreatment 72 postprocedure 72 timepoints 72 HbA 1c levels 71 interquartile range 71 nondiabetic patients 71 periprocedural 71 p = NS 70 MMSE score 70 mcg albinterferon alfa 2b 70 definite stent thrombosis 70 underwent resection 70 % CI #.#-#.# [003] 70 PASI scores 70 primary patency 70 androgen suppression 70 HBeAg seroconversion 69 Operative mortality 69 QTcF 69 posttransplant 69 Postoperative complications 69 P = .# 69 ipsilateral stroke 69 postoperative mortality 69 multivariate analyzes 69 mL/min/#.# m 2 69 posttest 69 postop 69 biochemical relapse 69 binary restenosis 69 pCR 68 biochemical recurrence 68 undetectable HBV DNA 68 endoscopic remission 68 PSA nadir 68 multivariable analysis 68 univariate analysis 68 morphometric vertebral fractures 68 CR nPR 68 perioperative mortality 68 postoperative chemotherapy 68 serum estradiol 68 symptom exacerbation 68 symptomatic VTE 68 TURBT 68 prospectively stratified 68 coronary revascularization 68 underwent surgical resection 68 postdose 68 p = #.# [003] 68 plasma cortisol 68 postoperative complication 68 NIHSS score 68 timepoint 68 chemoradiation therapy 67 genotypic resistance 67 affective psychosis 67 p = .# [002] 67 postdischarge 67 desvenlafaxine succinate 67 postoperative morbidity 67 β blockers 67 intraobserver 67 underwent CABG 67 clinicopathological features 67 achieved CCyR 67 nonfatal MI 67 radical nephrectomy 67 multivariable analyzes 67 insulin detemir 67 CI -#.# 67 % CI #.#-#.# [007] 67 NHANES III 67 attain statistical significance 67 angiographic restenosis 67 mg kg dose 67 APTIVUS r 67 oxycodone CR 66 adenotonsillectomy 66 evaluable subjects 66 HDRS 66 paclitaxel eluting stents 66 F FDG PET 66 relapsed MM 66 echocardiographic parameters 66 reinfarction 66 fibrinolytic therapy 66 MACCE 66 NIHSS 66 pancreatic resection 66 pT3 66 preoperative chemotherapy 66 XIENCE V demonstrated 66 sleeve lobectomy 66 TEAEs 66 radical retropubic prostatectomy 66 HER2 expression 66 REYATAZ r arm 66 NMIBC 66 colorectal adenoma 66 % Confidence Interval 66 adenoma recurrence 66 comparator arm 66 serum urate 66 Index CDAI 66 DAS# CRP 66 calculated creatinine clearance 66 hepatic resection 66 crossclamp 66 DES implantation 66 IOP lowering 66 ALT flares 66 postinjury 66 MADRS score 66 mcg QD 66 hip BMD 66 HbA1C levels 66 fibrinolysis 66 nadroparin 66 Secondary endpoints 66 methacholine challenge 66 KRAS mutations occur 66 hemoglobin A1c levels 66 virological response 66 DAS# remission 66 dose cohort 66 hypofractionated radiation 66 nonobstructive CAD 66 Postoperatively 66 baseline LDH 65 CCyR 65 Stent thrombosis 65 tipranavir r 65 secondary efficacy endpoint 65 preoperative PSA 65 Baseline characteristics 65 intima media thickness 65 prospectively defined 65 atazanavir ritonavir 65 femoral neck fracture 65 LV dysfunction 65 angiographic outcomes 65 dexmedetomidine 65 Secondary endpoints included 65 lumbar spine BMD 65 multivariable adjusted 65 statistically significant p = 65 glycosylated hemoglobin HbA1c 65 rFSH 65 Apgar scores 65 HSCT 65 Score DAS# 65 underwent percutaneous coronary 65 EDSS score 65 diameter stenosis 65 Secondary endpoints include 65 Postoperative 65 retrospective cohort 65 arterial thromboembolic events 65 HBeAg negative patients 65 SVR# 65 EDSS scores 65 placebo PBO 65 pretransplant 65 achieved ACR# 65 NNT = 65 placebo dexamethasone 65 Subgroup analysis 65 MMSE scores 65 Kaplan Meier estimates 65 hepatectomy 65 Primary endpoints 65 paroxysmal AF 65 Kaplan Meier analysis 65 titration phase 65 perioperative complications 65 VT VF 65 unstable angina pectoris 65 advanced adenomas 65 nonobese 65 SUVmax 65 statistical significance p 65 meta regression 65 inhospital mortality 65 lopinavir r arm 65 oncologic outcomes 65 confidence interval CI 65 serum phosphate 65 lymphadenectomy 65 recurrent VTE 65 advanced adenoma 65 spirometric 65 % CI #.#-#.# [008] 65 glycated hemoglobin HbA1c 65 #mg dosing group 65 virologic failure 65 Crohn Disease Activity 65 detectable HCV RNA 65 PRADAXA #mg 65 ALT normalization 65 serum aminotransferase levels 65 corticosteroid dose 65 TKAs 64 p ≤ 64 electrophysiologic 64 glycated hemoglobin levels 64 CDAI score 64 haematologic 64 noncardiac 64 asthma exacerbation 64 serum creatinine levels 64 multivariable adjustment 64 perioperatively 64 prespecified 64 femoral shaft fracture 64 Subgroup analyzes 64 OGTT 64 liver biopsies 64 progression TTP 64 baseline HbA1c 64 Infusion Reactions Severe 64 Exclusion criteria 64 psychiatric comorbidities 64 dalteparin 64 dosing cohort 64 NATRECOR ® 64 alanine aminotransferase ALT 64 low dose Iluvien 64 atrioventricular block 64 serum HBV DNA 64 tirofiban 64 Flu Cy 64 corrected QT interval 64 univariate 64 logistic regression model 64 lymphocytosis 64 specific antigen PSA 64 thyrotropin levels 64 renal cysts 64 #mg/day [001] 64 postoperative complications 64 PSADT 64 Bonferroni correction 64 unfractionated heparin UFH 64 peak VO2 64 coronary stenosis 64 asymptomatic carotid stenosis 64 BRCA2 mutation carriers 64 HbA1c levels 64 subtrochanteric 64 carotid stenosis 64 #.#/#.# mmHg [001] 64 intravitreal injections 64 oral anticoagulation 64 nondepressed 64 mg/m2 dose 64 severe exacerbations 64 sinus rhythm 64 MIRP 64 recurrent glioblastoma multiforme 64 -#.# log# 64 ejection fractions 64 SGRQ 64 hours postdose 64 tapentadol ER 64 diagnostic angiography 64 IELT 64 tertile 64 methotrexate monotherapy 64 tertiles 64 multivariate logistic regression 64 interobserver reliability 64 preoperative radiotherapy 64 HbA 1c 64 Complication rates 64 salpingo oophorectomy 64 bronchoalveolar lavage 64 complete cytogenetic response 64 arteriography 64 nonsignificant 64 GnRH agonist 64 SLNB 64 hematologic parameters 64 confidence intervals CIs 64 drug eluting stent implantation 64 Brief Psychiatric 64 dose titration 64 mg BID dose 64 serum phosphorous 64 Preoperatively 64 Secondary efficacy endpoints 64 pegylated interferon alfa 2b 64 nicardipine 64 ADCS ADL 64 ADAS cog 64 Montgomery Åsberg Depression 64 sd = 64 nephron sparing surgery 64 QRS duration 64 concurrent chemoradiation 63 univariate analyzes 63 conjugated equine estrogen 63 % CI #.#-#.# [006] 63 interobserver 63 antiretroviral naive 63 brachial artery flow 63 adrenalectomy 63 CIMZIA ™ 63 retrospectively analyzed 63 nonobese patients 63 primary percutaneous coronary 63 μmol L 63 OPCAB 63 thyroglobulin 63 ALT elevation 63 ultrasonographic 63 Platelet counts 63 multiple logistic regression 63 estimated GFR 63 urodynamic 63 lymph node dissection 63 preoperative intraoperative 63 echocardiographic 63 amoxicillin clavulanate 63 tumor histology 63 moderately emetogenic 63 ACR Pedi 63 normotensive 63 Kaplan Meier survival 63 CIMZIA TM certolizumab pegol 63 advanced neoplasia 63 pT2 63 overnight polysomnography 63 XIENCE V PROMUS Stent 63 multivariate adjustment 63 systolic dysfunction 63 hepatorenal syndrome 63 chest radiographs 63 troponin T 63 mmHg diastolic 63 endometrial carcinoma 63 NYHA functional class 63 intravenous diuretics 63 lispro 63 atorvastatin #mg 63 eplerenone 63 logistic regression analyzes 63 ischemia driven 63 asystole 63 VcMP 63 annualized relapse 63 postsurgical 63 radiotherapy RT 63 neurocognitive function 63 CPAP adherence 63 hip resurfacing arthroplasty 63 adenoidectomy 63 PaO 2 63 axillary node dissection 63 achieved statistical significance 63 divalproex sodium 63 RYGB 63 Hb A1C 63 coinfected patients 63 radical cystectomy 63 glomerular filtration 63 lung resection 63 cerebrovascular events 63 liver histology 63 elevated ALT 63 CR CRu 63 postoperative AF 63 confirmed CCyR 63 alteplase 63 Ishak fibrosis score 63 antiretroviral naïve 63 antibody titer 63 elevated LDH 63 abacavir lamivudine 63 SCr 63 moderate renal impairment 63 NATRECOR R 63 aspartate aminotransferase AST 63 endometrial thickness 63 visceral metastases 63 pericardial effusion 63 cerebrovascular accidents 63 oral olanzapine 63 dosing cohorts 63 fasting insulin 63 intact parathyroid hormone 63 salivary cortisol 63 systolic BP 63 8mg/kg 63 patients undergoing CABG 63 revascularizations 63 CYPHER Stent 63 concomitant AEDs 63 ARCALYST ® 63 multivariate Cox 63 Doxil ® 63 bivariate analyzes 63 racemic albuterol 63 ATACAND 63 ALND 63 nephrectomy 63 inhospital 63 HCV RESPOND 2 63 liver resection 63 confidence interval #.#-#.# 63 macroalbuminuria 63 Pharmacokinetic parameters 63 certolizumab 63 cystoscopic 63 carotid revascularization 63 DCCT 63 EURIDIS 63 6MWD 63 prospective multicenter study 63 adjunctive placebo 63 pretreatment baseline 63 postvaccination 63 mL kg 63 pamidronate 63 nonoperative 63 underwent coronary angiography 63 postoperative radiographs 63 FluCAM arm 63 leukocyte count 63 hemoglobin A1c HbA1c 63 STRIDE PD 63 apnea hypopnea 63 lymphocyte count 63 LVEF 63 AGILECT R 63 locoregional recurrence 63 HBeAg 63 virologic response 63 P ≤ 63 ischemic lesions 63 intermittent dosing 63 Taxus Stent 62 locoregional 62 postoperative bleeding 62 sonographic examinations 62 VAD implantation 62 transrectal ultrasound guided 62 unresectable HCC 62 Y BOCS 62 thrombocytopenic 62 irbesartan 62 left ventricular systolic 62 parathyroidectomy 62 median PFS 62 stent binary restenosis 62 overt nephropathy 62 lipid lowering agents 62 prospective observational studies 62 undergoing coronary angiography 62 QTc 62 thyroid carcinoma 62 solifenacin 62 LNG IUS 62 â ‰ ¥ 62 revascularization procedures 62 debulking surgery 62 NPH insulin 62 median sternotomy 62 tumor resection 62 serum HCV RNA 62 alanine aminotransferase 62 LV ejection fraction 62 IFN alfa 62 bolus dose 62 VATS lobectomy 62 response pCR 62 external beam radiotherapy 62 HOMA IR 62 pretest probability 62 Tasigna prolongs 62 sternal wound infections 62 pelvic lymphadenectomy 62 -#.# ± [002] 62 QTc intervals 62 urinary N telopeptide 62 neurologic progression 62 Psoriasis Area 62 ARB telmisartan 62 postoperatively 62 colectomy 62 carotid intima media 62 ICD implantation 62 methotrexate therapy 62 nadolol 62 recurrent venous thromboembolism 62 eculizumab therapy 62 serum concentrations 62 CC genotype 62 nodal metastases 62 patients evaluable 62 coronary angiograms 62 reintubation 62 flutamide 62 histological subtype 62 vaginal hysterectomy 62 hepatic enzyme 62 octreotide LAR 62 conditional logistic regression 62 deep venous thromboses 62 oral hypoglycemic agent 62 PCWP 62 FOLPI 62 elective PCI 62 transesophageal echocardiography 62 dose escalation phase 62 thyroidectomy 62 UACR 62 CVD mortality 62 disease progression TTP 62 IQR 62 Kaplan Meier estimate 62 abnormal p# biomarker 62 serum cortisol 62 MBq 62 radiographic progression 62 recurrent ischemia 62 radial artery grafts 62 mg administered orally 62 clinically meaningful improvement 62 seropositivity 62 parous women 62 covariate 62 mg TID 62 estimated glomerular filtration 62 metabolic parameters 62 CIN3 62 RVOT 62 Kaplan Meier curves 62 sociodemographic characteristics 62 logistic regression analysis 62 COPD exacerbation 62 syndromal 62 prespecified secondary 62 hyperacute 62 pneumonectomy 62 normothermic 62 transvaginal sonography 62 randomisation 62 electrical cardioversion 62 logistic regression models 62 serum urate levels 62 FOSRENOL ® 62 R0 resection 62 4mg/kg 62 colon resection 62 serum lipid levels 62 clinico pathological 62 carotid IMT 62 rt PA 62 mcg Albuferon 62 pmol L 62 serum ALT 62 FOLFOX4 62 neurologic complications 62 euthyroid 62 #mg BID [001] 62 thoracoscopic lobectomy 62 adjuvant cisplatin 62 ximelagatran 62 cytogenic 62 sirolimus stent 62 myocardial necrosis 62 GH deficiency 62 metabolite concentrations 62 n = 62 sociodemographic factors 62 venous thromboembolic disease 62 lung resections 62 beta blocker therapy 62 carotid artery stenting CAS 62 urine cytology 62 rebleeding 62 ADCS CGIC 62 oral prednisone 62 histologic subtype 62 glycosylated hemoglobin levels 62 nodular partial response 62 poststroke 62 MIRAPEX 62 aldosterone antagonist 62 ECOG PS 62 odds ratios ORs 62 CI #.#-#.# [001] 62 mIU ml 62 axillary node 62 CORE OM 62 severe neutropenia 62 prostate cancer CaP 62 detrusor overactivity 62 radical prostatectomy RP 62 nonfasting triglyceride levels 62 mg/m2 cohort 62 cytoreductive nephrectomy 62 stage IIIb IV 62 conventional angiography 62 Tumor Response 62 % CI #.#-#.# [004] 62 HF hospitalization 62 undergone radical prostatectomy 62 total thyroidectomy 62 BENICAR HCT 62 Folfox 62 pooled comparator 62 ug kg 62 #mg dose [002] 62 Ejection Fraction 62 subscore 61 Visual Analogue Scale VAS 61 preterm newborns 61 Histologic 61 serum PSA 61 atheroma volume 61 perioperative morbidity 61 liver transplant recipients 61 telaprevir dosing 61 liver metastasis 61 lowest tertile 61 IBDQ 61 clevidipine 61 FDA defined valvulopathy 61 seroprotection 61 histologically confirmed 61 atherosclerotic renal artery stenosis 61 tele ICU 61 invasive angiography 61 retropubic 61 Severity Index PASI 61 plasma creatinine 61 post operatively 61 dose Iluvien 61 PegIFN RBV 61 cerebral oxygenation 61 CDAI 61 5-fluorouracil/leucovorin 61 preoperative 61 activated partial thromboplastin 61 aneurysmal subarachnoid hemorrhage 61 CANCIDAS 61 ARCOXIA 61 exploratory endpoints 61 repeat revascularization 61 DAS# scores 61 ‰ ¥ 61 experienced virologic failure 61 cTnI 61 cerebral angiography 61 subcutaneous enoxaparin 61 extrapyramidal symptoms 61 mm Hg diastolic 61 hypokalemia 61 % CI #.#-#.# [001] 61 Montgomery Asberg Depression 61 elevated troponin 61 intraoperative complications 61 dimensional echocardiography 61 tamsulosin 61 BMI z 61 ANCOVA 61 HIV HCV coinfected 61 amisulpride 61 clinicopathological 61 neoadjuvant 61 angiographically 61 iodixanol 61 depressive symptom 61 GOUT 61 Kruskal Wallis test 61 ziprasidone 61 baseline Hb 61 mild renal insufficiency 61 receiving ISENTRESS 61 cranial irradiation 61 UPDRS 61 hyperalgesia 61 WOMAC scores 61 bilateral TKA 61 angioplasty stenting 61 Cardiopulmonary bypass 61 ropivacaine 61 FFNS 61 de novo AML 61 nonoperative treatment 61 salivary flow 61 β blocker 61 microbiologically evaluable 61 nonvertebral fracture 61 systemic corticosteroids 61 hsCRP levels 61 elevated IOP 61 Arch Intern Med 61 bivariate analysis 61 clopidogrel pretreatment 61 reoperations 61 CTEPH 61 lipid lowering therapy 61 μg dL 61 rimonabant #mg 61 acute cholecystitis 61 QTc prolongation 61 hemodynamic variables 61 active comparator 61 foveal thickness 61 extubation 61 tipranavir ritonavir 61 MoxDuo TM IR 61 Scale EDSS 61 Index CDAI score 61 lamivudine monotherapy 61 highest tertile 61 HBV DNA 61 hemoglobin concentrations 61 ratio ICER 61 virologic breakthrough 61 interrater reliability 61 colorectal liver metastases 61 ± SD 61 fluoxetine paroxetine 61 thromboembolic 61 mammographic density 61 premorbid 61 transurethral resection 61 total abdominal hysterectomy 61 creatinine levels 61 adnexal mass 61 wedge resection 61 hematologic toxicity 61 mCi kg 61 NovoSeven ® 61 WOMAC pain 61 Patency 61 mcg BID 61 salmeterol HFA MDI 61 sonographically guided 61 premenopause 61 graft occlusion 61 STN stimulation 61 p = .# [001] 61 nonpsychotic 61 microg 61 vasopressor 61 Kaplan Meier 61 salmeterol fluticasone 61 neoadjuvant therapy 61 peri procedural 61 carotid endarterectomy CEA 61 cardiac perfusion 61 NSTEMI 61 comorbid depression 61 hematological parameters 61 invasive carcinomas 61 neostigmine 61 baseline FEV 61 fasting plasma glucose FPG 61 infarct size 61 Coronary Artery Bypass Graft 61 systolic function 61 q#h 61 fraction LVEF 61 androgen ablation 61 FDG PET scans 61 achieved sustained virological 61 nonsignificant difference 61 CRp 61 tumor progression TTP 61 myocardial viability 61 mg QD 61 LAGB 61 hepatic metastases 61 mesalamine granules 61 oxygen desaturation 61 treated nonsurgically 61 tolterodine ER 61 EBRT 61 postmenopausal osteoporotic women 61 postoperative 61 Univariate 61 noncardiovascular mortality 61 histologic 61 incontinence episodes 61 clinically meaningful improvements 61 bronchial reactivity 61 anastomotic leak 61 systemic corticosteroid 61 composite endpoint 61 eszopiclone 61 Erectile function 61 AST ALT 61 underwent angiography 61 Univariate analysis 61 arterial oxygen saturation 61 + PH# 61 CYP#D# inhibitor 61 serum calcium levels 61 μg liter 61 randomized blinded 61 duplex ultrasonography 61 vertebral fracture 61 peginterferon 61 upper endoscopy 61 chlorambucil 61 hypogonadal men 61 Angiographic 61 neutrophil counts 61 nonadherence 61 urine albumin 61 NIH CPSI 61 μg kg 61 aPTT 61 esophageal carcinoma 61 piperacillin tazobactam 61 SLN biopsy 61 placebo p = 61 CHAMPION PCI 61 serum clusterin levels 61 ACEI ARB 61 oral allopurinol 61 LVSD 61 plasma uric acid 61 radiochemotherapy 61 mediastinitis 61 coronary CTA 61 IV bolus 61 #mmHg [001] 61 hemoglobin Hb 61 Fontan procedure 61 sternotomy 61 Rating Scale MADRS 61 CHD mortality 61 #.#mg/dL 61 #.#ng/ml 61 follicular phase 61 acetabular fracture 61 chest radiography 61 reperfusion therapy 61 Viral load 61 HRCT 60 CT perfusion 60 hypoglycemic events 60 #Gy 60 recanalization 60 Poisson regression 60 ER CHOP 60 Hematologic 60 rCBF 60 urate lowering therapy 60 blind placebo 60 symptomatic intracerebral hemorrhage 60 VaD 60 nmol l 60 hemodynamic parameters 60 polytherapy 60 hemodynamically significant 60 esophagogastroduodenoscopy 60 polysomnography PSG 60 cytoreductive surgery 60 secondary efficacy endpoints 60 somatostatin analog 60 titrated glipizide 60 inhaled budesonide 60 saline infusion 60 highly emetogenic 60 renal biopsy 60 cGy 60 ancrod 60 left ventricular dysfunction 60 receiving VICTRELIS 60 cardiac repolarization 60 #mg/day [002] 60 platelet reactivity 60 prednisone prednisolone 60 aged ≥ 60 neurologic outcomes 60 Response Evaluation Criteria 60 thorough QT 60 Breslow thickness 60 variance ANOVA 60 autologous SCT 60 QALE 60 depressive symptomatology 60 Major Adverse Cardiac 60 ug dose 60 doxorubicin docetaxel 60 #q# deletion syndrome 60 EBUS FNA 60 bortezomib refractory 60 serum uric acid 60 dyspnoea 60 mean baseline HbA1c 60 symptomatic intracranial 60 retinal thickness 60 transthoracic 60 Febrile neutropenia 60 esophageal acid 60 underwent liver transplantation 60 intravesical therapy 60 PREZISTA r arm 60 percutaneous vertebroplasty 60 Hb A1c 60 symptomatic carotid stenosis 60 cecal intubation 60 familial aggregation 60 oral antidiabetic medication 60 unpaired t 60 remission CR 60 R# #mg BID 60 neutropaenia 60 Pred Forte 60 scintigraphic 60 pathologic fractures 60 Fasting plasma glucose 60 HCV SPRINT 60 IPSS 60 nondiagnostic 60 mg kg Hematide 60 TAXUS Express Stent 60 intratympanic 60 CIMZIA TM 60 calcaneal fractures 60 antiandrogen 60 distant metastasis 60 pathologic diagnosis 60 lymphopenia 60 CIN2 + 60 dacarbazine chemotherapy 60 mIU L 60 paresthesias 60 albumin excretion 60 SSRI SNRI 60 pyridostigmine 60 BYSTOLIC 60 GSK# [001] 60 #mg QD [001] 60 OADs 60 interquartile range IQR 60 azoospermia 60 CI #.#-#.# [002] 60 #mg/m# [002] 60 intravenous dosing 60 eNO 60 ng dL 60 pulmonary resection 60 RECORD1 60 pulmonary artery banding 60 percutaneous transluminal coronary angioplasty 60 tacrolimus ointment 60 imatinib therapy 60 QIDS SR 60 Fasting blood glucose 60 malignant polyps 60 HBeAg positive patients 60 gross hematuria 60 pathologic examination 60 DAPT 60 Ebstein anomaly 60 concomitant antibiotics 60 recurrent DVT 60 axillary lymph node 60 Meta analyzes 60 argatroban 60 mediastinal 60 noninferiority 60 doxorubicin cyclophosphamide 60 esophagectomy 60 MetS 60 chemoradiation 60 CrCl 60 YMRS 60 sirolimus eluting stents 60 statin monotherapy 60 dose proportionality 60 plain radiographs 60 androgen deprivation 60 coronary calcification 60 placebo fluoxetine 60 total hip arthroplasties 60 Timed Walk 60 SYNTAX trial 60 renal cell carcinomas 60 discontinuations due 60 NSTE ACS 60 TMP SMX 60 HIV RNA 60 lesional 60 HAM D# 60 antiarrhythmic drug 60 distal radial fractures 60 pulmonary exacerbation 60 fluticasone salmeterol

Back to home page